Gwen Nichols
Hematology & Oncology · New York, NYNPI 1801954326
Payments from drug & device makers
Across 5 payments — averaging $185,336 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astrazeneca UK Limited$922K
- E.r. Squibb & Sons, L.L.C.$3K
- Amgen$1K
- Gilead$351
Across 4 payments — averaging $1186.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$5K
What the payments were for
- Consulting fees$4,22592%
- Food & beverage$3518%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astrazeneca UK Limited | 1 | $922,102 |
| E.r. Squibb & Sons, L.L.C. | 1 | $3,125 |
| Amgen | 1 | $1,100 |
| Gilead | 2 | $351 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$926,678 in reported general payments places this provider in the 85th percentile of 967 hematology & oncology providers in New York.
Other hematology & oncology in New York
- Vicky MakkerNew York$27.1M
- Alison MoskowitzNew York$22.7M
- Ajai ChariNew York$22.4M
- Yelena JanjigianNew York$16.9M
- Alexander LesokhinNew York$11.9M
- John MascarenhasNew York$11.8M
- Maria PalombaNew York$11.6M
- Scott TagawaNew York$10.3M
- Mohammad Abdul HayNew York$9.9M
- Joshua SabariNew York$9.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.